Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RED: Dapagliflozin vs Gliclazide on Renal Physiology in T2DM
NCT02682563Phase 4Completed
- Start
- Feb 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM). Started Feb 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02682563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682563.